🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/10/2012 | 44,06 | 44,33 | 43,69 | 44,22 | +0,13% | 1,45% | 7.371.318 |
| 05/10/2012 | 44,29 | 44,37 | 43,76 | 44,16 | +0,35% | 1,38% | 12.463.864 |
| 04/10/2012 | 43,80 | 44,27 | 43,75 | 44,01 | +0,74% | 1,18% | 9.383.582 |
| 03/10/2012 | 43,42 | 43,77 | 43,20 | 43,68 | +0,68% | 1,32% | 8.861.678 |
| 02/10/2012 | 43,35 | 43,51 | 43,03 | 43,39 | +0,55% | 1,10% | 7.786.116 |
| 01/10/2012 | 42,91 | 43,50 | 42,91 | 43,15 | +0,27% | 1,38% | 8.964.278 |
| 28/09/2012 | 42,99 | 43,14 | 42,73 | 43,03 | -0,29% | 0,95% | 13.097.170 |
| 27/09/2012 | 43,01 | 43,36 | 42,95 | 43,16 | +0,49% | 0,95% | 10.306.346 |
| 26/09/2012 | 43,04 | 43,29 | 42,94 | 42,95 | -0,22% | 0,82% | 13.260.134 |
| 25/09/2012 | 43,15 | 43,61 | 42,81 | 43,04 | -0,07% | 1,86% | 13.419.850 |
| 24/09/2012 | 42,89 | 43,18 | 42,74 | 43,07 | +0,51% | 1,02% | 10.468.786 |
| 21/09/2012 | 42,89 | 43,18 | 42,81 | 42,85 | +0,04% | 0,87% | 21.226.821 |
| 20/09/2012 | 42,33 | 42,91 | 42,32 | 42,83 | +0,85% | 1,40% | 10.443.320 |
| 19/09/2012 | 42,10 | 42,73 | 42,07 | 42,47 | +0,98% | 1,56% | 10.289.369 |
| 18/09/2012 | 41,76 | 42,12 | 41,69 | 42,06 | +0,18% | 1,03% | 7.895.632 |
| 17/09/2012 | 41,49 | 41,98 | 41,49 | 41,98 | +0,87% | 1,20% | 11.538.899 |
| 14/09/2012 | 42,51 | 42,51 | 41,45 | 41,62 | -2,33% | 2,49% | 17.331.195 |
| 13/09/2012 | 42,06 | 42,66 | 41,99 | 42,61 | +0,29% | 1,59% | 12.429.175 |
| 12/09/2012 | 42,32 | 42,53 | 42,28 | 42,49 | +0,45% | 0,59% | 9.378.028 |
| 11/09/2012 | 42,32 | 42,53 | 42,25 | 42,30 | +0,16% | 0,65% | 8.975.596 |
| 10/09/2012 | 41,96 | 42,35 | 41,88 | 42,23 | +0,48% | 1,11% | 9.427.284 |
| 07/09/2012 | 42,40 | 42,40 | 41,91 | 42,03 | -0,43% | 1,17% | 8.738.538 |
| 06/09/2012 | 41,65 | 42,23 | 41,62 | 42,21 | +1,84% | 1,47% | 10.349.419 |
| 05/09/2012 | 41,40 | 41,54 | 41,11 | 41,45 | +0,44% | 1,04% | 8.734.870 |
| 04/09/2012 | 41,16 | 41,40 | 40,91 | 41,27 | +0,46% | 1,21% | 25.771.368 |
| 31/08/2012 | 41,35 | 41,58 | 40,94 | 41,08 | -0,16% | 1,55% | 28.906.355 |
| 30/08/2012 | 40,90 | 41,29 | 40,69 | 41,15 | +0,14% | 1,47% | 8.964.173 |
| 29/08/2012 | 40,98 | 41,26 | 40,73 | 41,09 | +0,54% | 1,28% | 7.973.289 |
| 28/08/2012 | 41,00 | 41,16 | 40,79 | 40,87 | -0,51% | 0,91% | 8.419.842 |
| 27/08/2012 | 41,01 | 41,26 | 40,88 | 41,08 | -0,16% | 0,93% | 8.122.943 |